Poland· PL-100515522
Kostaive
A covid-19, rna-based vaccine product containing zapomeranum, registered in Poland by Arcturus Therapeutics Europe B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Covid-19, rna-based vaccine is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Covid-19, rna-based vaccine · ATC J07BN01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Zapomeranum
- Manufacturer
- Arcturus Therapeutics Europe B.V.
- Country
- Poland (PL)
- ATC code
- J07BN01
- ATC class
- Covid-19, RNA-based vaccine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Covid-19, rna-based vaccine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumKostaiveArcturus Therapeutics Europe
- CzechiaKOSTAIVESeqirus Netherlands B.V., Amsterdam
- FinlandKostaiveSeqirus Netherlands B.V.
- IrelandKostaive powder for dispersion for injection. COVID-19 sa-mRNA VaccineArcturus Therapeutics Europe B.V.
- IcelandKostaiveSeqirus Netherlands B.V.
- NetherlandsKostaive poeder voor dispersie voor injectie COVID-19 sa-mRNA-vaccinSeqirus Netherlands B.V.
- SwedenKostaive 5 mikrogram/dos Pulver till injektionsvätska, dispersionSeqirus Netherlands B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Kostaive
- Liechtenstein · Kostaive
- Norway · Kostaive
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dff631b3-b3c8-4c55-a462-23c4c617ecc7 GET /v1/drugs/dff631b3-b3c8-4c55-a462-23c4c617ecc7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania dyspersji do infuzji",
"source": "urpl",
"strength": "5 mcg/dawkę",
"packaging": "Rp ¦ EU/1/24/1873/001 ¦ 161122\n20 fiol. 80 mcg proszku",
"substance": "Zapomeranum 5 mcg/dawkę",
"common_name": "Zapomeranum",
"pl_product_id": "100515522",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about covid-19, rna-based vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.